Matrix metalloproteinase-3 and intracranial arterial dolichoectasia

Annals of Neurology

Volumn 67, Issue 4, 2010, Pages 508-515

  Pico, Fernando ^a,b   Jacob, Marie Paule ^b   Labreuche, Julien ^b   Soufir, Nadem ^b   Touboul, Pierre Jean ^b   Benessiano, Joëlle ^b   Cambien, François ^c   Grandchamp, Bernard ^b   Michel, Jean Baptiste ^b   Amarenco, Pierre ^b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; GENOMIC DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; STROMELYSIN;

ADULT; ARTERY DIAMETER; ARTERY DILATATION; ARTERY DISEASE; ARTICLE; BASILAR ARTERY; BRAIN ARTERY; BRAIN INFARCTION; CAUCASIAN; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRACRANIAL ARTERIAL DOLICHOECTASIA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; STROKE;

ADULT; AGED; BRAIN INFARCTION; CEREBRAL ARTERIAL DISEASES; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 77951753639     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21922     Document Type: Article

References (35)

1. Caplan LR. Dilatative arteriopathy (dolichoectasia): what is known and not known. Ann Neurol 2005;57:469-471.
2. Pico F, Labreuche J, Touboul PJ, et al. Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol 2005;57:472-479. (Pubitemid 40471155)
3. Bogousslavsky J, Regli F, Maeder P, et al. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology 1993;43:1528-1533. (Pubitemid 23230537)
4. Sacks JG, Lindenburg R. Dolicho-ectatic intracranial arteries: symptomatology and pathogenesis of arterial elongation and distention. Johns Hopkins Med J 1969;125:95-106.
5. Pico F, Biron Y, Bousser MG, Amarenco P. Concurrent dolichoectasia of basilar and coronary arteries. Neurology 2005;65: 1503-1504. (Pubitemid 41552796)
6. Michel JB. Acquired abdominal aortic aneurysm. Nephrol Dial Transplant 1998;13(suppl 4):20-24.
7. Swaye PS, Fisher LD, Litwin P, et al. Aneurysmal coronary artery disease. Circulation 1983;67:134-138.
8. Pico F, Labreuche J, Touboul PJ, Amarenco P. Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology 2003;61:1736-1742. (Pubitemid 38020821)
9. Virmani R, Robinowitz M, Atkinson JB, et al. Acquired coronary arterial aneurysms: an autopsy study of 52 patients. Hum Pathol 1986;17:575-583. (Pubitemid 16097450)
10. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006;69:636-645. (Pubitemid 43139726)
11. Lamblin N, Bauters C, Hermant X, et al. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 2002;40:43-48. (Pubitemid 34701375)
12. Fontaine V, Jacob MP, Houard X, et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002;161:1701-1710. (Pubitemid 35265529)
13. Deguara J, Burnand KG, Berg J, et al. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum Mol Genet 2007;16:3002-3007. (Pubitemid 350131318)
14. Touboul PJ, Elbaz A, Koller C, et al. Common carotid artery intima-media thickness and brain infarction: the Etude du Profil Genetique de l'Infarctus Cerebral (GENIC) case-control study. The GENIC Investigators. Circulation 2000;102:313-318. (Pubitemid 30457582)
15. Abboud H, Berroir S, Labreuche J, et al. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol 2006;59:691-699.
16. Olivot JM, Labreuche J, Aiach M, Amarenco P. Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke 2004;35:1946-1951. (Pubitemid 38971881)
17. Pico F, Labreuche J, Gourfinkel-An I, Amarenco P. Basilar artery diameter and 5-year mortality in patients with stroke. Stroke 2006;37:2342-2347. (Pubitemid 44337181)
18. Rossignol P, Cambillau M, Bissery A, et al. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors. Clin Exp Pharmacol Physiol 2008;35:464-469. (Pubitemid 351326780)
19. Badier-Commander C, Verbeuren T, Lebard C, et al. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000;192:105-112.
20. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003;57:195-202.
21. Silence J, Lupu F, Collen D, Lijnen HR. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001;21:1440-1445. (Pubitemid 34219805)
22. Borges LF, Touat Z, Leclercq A, et al. Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections. Hum Pathol 2009;40:306-313.
23. Medley TL, Kingwell BA, Gatzka CD, et al. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003;92:1254-1261.
24. Samnegard A, Silveira A, Lundman P, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005;258:411-419. (Pubitemid 41546556)
25. White AJ, Duffy SJ, Walton AS, et al. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 2007;75:813-820.
26. Mattey DL, Nixon NB, Dawes PT, et al. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 2004;5:147-149.
27. Wilson WR, Choke EC, Dawson J, et al. Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair. Vascular 2008;16:248-252.
28. Pico F, Labreuche J, Cohen A, et al. Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta. Neurology 2004;63:2016-2021. (Pubitemid 39636245)
29. Yoon S, Tromp G, Vongpunsawad S, et al. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999;265:563-568.
30. Peters DG, Kassam A, St Jean PL, et al. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 1999;30:2612-2616.
31. Aoki T, Kataoka H, Morimoto M, et al. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007;38:162-169. (Pubitemid 46035622)
32. Rosell A, Alvarez-Sabin J, Arenillas JF, et al. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005;36:1415-1420. (Pubitemid 40967504)
33. Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 2003;34:2165-2170. (Pubitemid 37099830)
34. Lamblin N, Gautier C, Le Tourneau T, et al. Prospective aortic screening in men with coronary aneurysms. J Am Coll Cardiol 2006;47:1227-1229.
35. Huang CY, Wu TC, Lin WT, et al. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients. Eur J Clin Invest 2006;36:76-84.